Patent applications published 16 March 2011
Selected patent applications from the weekly European Patents Bulletin
- Interleukin 10 receptor (IL-10R) antibodies and methods of use
Kyowa Hakko Kirin Co; Kato, Shinichiro; Soloff Nugent, Rachel; Tahara, Tomoyuki; Song, Aihua; Rogers, Paul 2293667*
- Antimicrobial compsns and methods of use
Zurex Pharma 2293668*
- Antimicrobial system
The Queen’s University of Belfast 2293669*
- Compsns and methods for nail fungus treatment
Arch Chemicals 2293670*
- Small molecule inhibitors for the treatment or prevention of dengue virus infection
Siga Technologies 2293671*
- Novel inverse lattices based on fatty alcohol ethers, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compsns comprising same
Société d’Exploitation de Produits pour les Industries Chimiques 2293770*
- Novel inverse lattices that are free of oxyethylene derivatives, and cosmetic, dermocosmetic, dermopharmaceutical or pharmaceutical compsns comprising same
Société d’Exploitation de Produits pour les Industries Chimiques 2293771*
- Hydrogel capable of containing and conveying cells
Politecnico di Milano 2293775*
- Compsn comprising an antibiotic and a corticosteroid
Intervet International 2293778*
- Oral contraceptive dosage forms comprising a progestogen dispersed in an enteric polymer and further comprising an estrogen
Evestra 2293779*
- Orodispersible mannitol
Roquette Freres 2293780*
- Granulation of active pharmaceutical ingredients
LEK Pharmaceuticals 2293781*
- Stable benzimidazole formulation
Dexcel Pharma Technologies 2293782*
- Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
Tolmar Therapeutics 2293784*
- Nanoparticles containing a peptide, vectors containing the same and pharmaceutical uses of said nanoparticles and said vectors
Centre National de la Recherche Scientifiques; Université de Strasbourg 2293785*
- Tablettable chewing gums comprising nicotine and a buffering agent
Novartis 2293786*
- Nanoemulsions for treating fungal, yeast and mould infections
Nanobio Corp 2293787*
- Combination of a nicotinic receptor partial agonist and of an acetylcholinesterase inhibitor, pharmaceutical compsn containing same and use thereof in the treatment of cognitive disorders
Sanofi-Aventis 2293790*
- Pharmaceutical compsns of entacapone co-micronised with sugar alcohols
Wockhardt Research Centre 2293791*
- Diaryl ureas for treating heart failure
Bayer Schering Pharma Aktiengesellschaft 2293792*
- 2,5-disubstituted imidazo[4,5-C]pyridines for treating muscular dystrophy
BioMarin IGA 2293793*
- Methods of treating mammals with eustachian tube dysfunctions
The University of Melbourne 2293794*
- Pharmaceutical combination
Boehringer Ingelheim International 2293795*
- Telaprevir dosing regimen
Janssen Pharmaceutica; Vertex Pharmaceuticals 2293796*
- Pregesterone antagonists such as CDB-4124 in the treatment of endometriosis, uterine fibroids, dysmenorrhea, breast cancer etc
Repros Therapeutics 2293797*
- Pregesterone antagonists such as CDB-4124 in the treatment of breast cancer
Repros Therapeutics 2293798*
- Sialic acid to support salivation
Nestec 2293799*
- Compsns and methods for treatment of ear disorders
Quark Pharmaceuticals 2293800*
- Method for preventing corticosteroid usage
NV Nutricia 2293801*
- Lactose compsns with decreased lactose content
Ritter Pharmaceuticals 2293802*
- Immune system stimulating nutrition
NV Nutricia 2293803*
- Herpes simplex virus (HSV) with modified tropism, uses and processes or preparation thereof
Alma Mater Studiorum — Universita’ di Bologna 2293804*
- Lozenge compsn for treating inflammatory diseases of the mouth and pharynx
Maria Clemetine Martin Klosterfrau Vertriebsgesellschaft 2293805*
- Oral herbal compsn for the treatment of oral candidiasis
Piramal Life Sciences 2293806*
- Cyclopenta[G]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia
BTG International 2293807*
- A synthetic peptide containing bone forming peptide 1 (BFP 1) for stimulating osteoblast differentiation, and pharmaceutical compsn comprising the synthetic peptide
Industry Foundation of Chonnam National University 2293808*
- Peptidyl diacylglycerides
Therimunex Pharmaceuticals 2293809*
- Compsns and methods for preventing or treating AIDS
Université de la Méditerranée; Centre National de la Recherche Scientifique 2293810*
- Derivatised hybrid peptides of amylin and salmon calcitonin
Novo Nordisk 2293811*
- Method for isolating cells and disease vectors from bodily fluids
Heinrich, Hans-Werner 2293812*
- Nanoemulsion vaccines*
The Regents of the University of Michigan 2293813*
- Nanoemulsion adjuvants
The Regents of the University of Michigan 2293814*
- Synergistic immunogenic fusion protein-polysaccharide conjugate
Children’s Medical Center Corp 2293815*
- Methods for the treatment of rheumatoid arthritis
XOMA Technology 2293816*
- Stabilised liquid formulation
Sandoz 2293817*
- Conjugates of a cholinesterase moiety and a polymer
Nektar Therapeutics 2293818*
- Method for diagnosing cancers expressing the HER2 receptor or its truncated variants
Fundació Privada Institut De Rercerca Hospital Universitari Vall Hebron; Fundació Privada Institució Catalana De Recerca I Estudia Avancats; Fundació Privada Institut d’Investigació Oncològica de Vall d’Hebron 2293819*
- Depsipeptides and their therapeutic use
Karus Therapeutics 2293845*
- Depsipeptides and their therapeutic use
Karus Therapeutics 2293846*
- Depsipeptides and their therapeutic use
Karus Therapeutics 2293847*
- Oral compsns and uses thereof
Colgate-Palmolive 2293849*
- Orally active curcuminoid compounds
Laila Pharmaceuticals 2294049*
- Bis-aryl compounds for use as medicaments
Biolipox 2294050*
- Alpha-substituted N-sulphonyl glycine amides antagonists of CCR10, compsns containing the same and methods for using them
Boehringer Ingelheim 2294051*
- Process for the preparation of ezetimine and compsn containing it
LEK Pharmaceuticals 2294052*
- Glucokinase activators
Takeda San Diego 2294053*
- A preparation method of (4S, 5R)-semiester
DSM IP Assets; Fudan University 2294054*
- Salts comprising a pyrimidinecarboxylic acid derivative for cosmetic use
Merck Patent 2294055*
- Bosentan salts
Synthon 2294056*
- Process for preparing a crystalline form compound of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydro-benzo[d]isoxazol-4-one
Abiogen Pharma 2294057*
- Disubstituted phthalazine hedgehog pathway antagonists
Eli Lilly 2294061*
- Substituted 4-(indazolyl)-1,4-dihydro-pyridines and methods of use thereof
Bayer Schering Pharma AG 2294062*
- Pyrrolidine ether derivatives as NK3 receptor antagonists
F Hoffmann-La Roche 2294063*
- Process for the purification of rabeprazole sodium
Hetero Research Foundation 2294064*
- Indolyl-pyridone derivatives having checkpoint kinase 1 inhibitory activity
Vernalis (R&D) 2294065*
- Benzoimidazoles as prolyl hydroxylase inhibitors
Janssen Pharmaceutica 2294066*